Evaxion Biotech

EVAXION BIOTECH A/S is a clinical-stage biotechnology company designing AI-driven immunotherapies. With our proprietary and scalable AI technology, we decode the human immune system to discover and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Evaxion Biotech has a broad pipeline of new product candidates, including three patient-specific cancer immunotherapies.